Miao Y, Fan F, Cheng Y, Jia L, Song S, Huan X
Nat Commun. 2025; 16(1):2526.
PMID: 40087304
DOI: 10.1038/s41467-025-56981-w.
Wang Z, Kang W, Yu R
Front Oncol. 2025; 15:1530924.
PMID: 40061891
PMC: 11885118.
DOI: 10.3389/fonc.2025.1530924.
Chen C, Addepalli K, Soldan S, Castro-Munoz L, Preston-Alp S, Patel R
J Med Virol. 2025; 97(1):e70168.
PMID: 39821265
PMC: 11740287.
DOI: 10.1002/jmv.70168.
Bellaart A, Brambila A, Xu J, Mendez Diaz F, Deep A, Anzola J
bioRxiv. 2024; .
PMID: 39416052
PMC: 11482875.
DOI: 10.1101/2024.10.09.617493.
Li X, Pan J, Zheng P
Front Oncol. 2024; 14:1427663.
PMID: 39346740
PMC: 11427698.
DOI: 10.3389/fonc.2024.1427663.
High-throughput structure determination of an intrinsically disordered protein using cell-free protein crystallization.
Kojima M, Abe S, Furuta T, Hirata K, Yao X, Kobayashi A
Proc Natl Acad Sci U S A. 2024; 121(25):e2322452121.
PMID: 38861600
PMC: 11194560.
DOI: 10.1073/pnas.2322452121.
A protein sequence-based deep transfer learning framework for identifying human proteome-wide deubiquitinase-substrate interactions.
Liu Y, Li D, Zhang X, Xia S, Qu Y, Ling X
Nat Commun. 2024; 15(1):4519.
PMID: 38806474
PMC: 11133436.
DOI: 10.1038/s41467-024-48446-3.
Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion.
Hsu S, Chou C, Lin I, Chang W, Kuo I, Chiu C
Cell Commun Signal. 2024; 22(1):259.
PMID: 38715050
PMC: 11075295.
DOI: 10.1186/s12964-024-01633-7.
DoUBLing up: ubiquitin and ubiquitin-like proteases in genome stability.
Foster B, Wang Z, Schmidt C
Biochem J. 2024; 481(7):515-545.
PMID: 38572758
PMC: 11088880.
DOI: 10.1042/BCJ20230284.
Carcinogenic mechanisms of virus-associated lymphoma.
Zhang Y, Guo W, Zhan Z, Bai O
Front Immunol. 2024; 15:1361009.
PMID: 38482011
PMC: 10932979.
DOI: 10.3389/fimmu.2024.1361009.
Repurposing of US-FDA-approved drugs as negative modulators of ubiquitin specific protease-7 (USP7).
Zadi S, Javaid S, Atia-Tul-Wahab , Zafar H, Awais M, Maslennikov I
Heliyon. 2024; 10(5):e26345.
PMID: 38468948
PMC: 10925992.
DOI: 10.1016/j.heliyon.2024.e26345.
Friend or foe? Reciprocal regulation between E3 ubiquitin ligases and deubiquitinases.
Bolhuis D, Emanuele M, Brown N
Biochem Soc Trans. 2024; 52(1):241-267.
PMID: 38414432
PMC: 11349938.
DOI: 10.1042/BST20230454.
Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma.
Zhang T, Su F, Wang B, Liu L, Lu Y, Su H
Oncogene. 2024; 43(16):1190-1202.
PMID: 38409551
DOI: 10.1038/s41388-024-02985-7.
Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells.
Zhang K, Sun T, Li W, Guo Y, Li A, Hsieh M
Cell Commun Signal. 2023; 21(1):319.
PMID: 37946202
PMC: 10634000.
DOI: 10.1186/s12964-023-01320-z.
The roles of ubiquitination in AML.
Wei Z, Su L, Gao S
Ann Hematol. 2023; 103(9):3413-3428.
PMID: 37603061
DOI: 10.1007/s00277-023-05415-y.
miR-221/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia.
Pei H, Peng Z, Zhuang X, Wang X, Lu B, Guo Y
Cell Death Discov. 2023; 9(1):249.
PMID: 37454155
PMC: 10349814.
DOI: 10.1038/s41420-023-01537-4.
MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis.
Fang D, Hu H, Zhao K, Xu A, Yu C, Zhu Y
Adv Sci (Weinh). 2023; 10(26):e2303336.
PMID: 37438558
PMC: 10502657.
DOI: 10.1002/advs.202303336.
SCML2 contributes to tumor cell resistance to DNA damage through regulating p53 and CHK1 stability.
Peng Q, Shi X, Li D, Guo J, Zhang X, Zhang X
Cell Death Differ. 2023; 30(7):1849-1867.
PMID: 37353627
PMC: 10307790.
DOI: 10.1038/s41418-023-01184-3.
Epstein-Barr Virus History and Pathogenesis.
Yu H, Robertson E
Viruses. 2023; 15(3).
PMID: 36992423
PMC: 10056551.
DOI: 10.3390/v15030714.
The termination of UHRF1-dependent PAF15 ubiquitin signaling is regulated by USP7 and ATAD5.
Miyashita R, Nishiyama A, Qin W, Chiba Y, Kori S, Kato N
Elife. 2023; 12.
PMID: 36734974
PMC: 9943068.
DOI: 10.7554/eLife.79013.